Skip directly to search Skip directly to A to Z list Skip directly to navigation Skip directly to page options Skip directly to site content
Family Health History PHGKB

Specific PHGKB|Family Health History PHGKB|PHGKB

Last Posted: Mar 27, 2023
spot light Spotlight

Predicting personal cardiovascular disease risk based on family health history: Development of expert-based family criteria for the general population
T DIjsktra et al, EJHG, March 27, 2023

A Delphi procedure carried out in a larger group of expert physicians led to consensus on five family criteria that focus on cardiovascular events at young age (i.e., sudden death, any CVD, implantable cardioverter-defibrillator, aortic aneurysm) and/or an inherited CVD in one or more close relatives. We then applied these family criteria to a high-risk cohort from a clinical genetics department and demonstrated that they have substantial diagnostic accuracy. After further evaluation in a general population cohort, we decided to only use the family criteria for first-degree relatives.

Expanding Family Health History to Include Family Medication History
SB Haga et al, J Per Med, Feb 2023

The collection of family health history (FHH) is an essential component of clinical practice and an important piece of data for patient risk assessment. However, family history data have generally been limited to diseases and have not included medication history. Family history was a key component of early pharmacogenetic research, confirming the role of genes in drug response. With the substantial number of known pharmacogenes, many affecting response to commonly prescribed medications, and the availability of clinical pharmacogenetic (PGx) tests and guidelines for interpretation, the collection of family medication history can inform testing decisions.

A Piece of a Puzzle – The All of Us Research Program and Cancer
K Littrell et al, CDC Blog Post, February 27, 2023

The All of Us research program has vast potential for making an impact on population health using the new tools of precision medicine. Pairing genomic data with family health history will be critical for clinical utility. The genetic and environmental data that the All of Us research program promises are all important pieces of the puzzle in the progress towards cancer prevention and control.

Risk of Sudden Infant Death Syndrome Among Siblings of Children Who Died of Sudden Infant Death Syndrome in Denmark.
Charlotte Glinge et al. JAMA network open 2023 1 (1) e2252724

Is a family history of sudden infant death syndrome (SIDS) associated with increased risk of subsequent SIDS compared with the general population? In this cohort study of more than 2.6 million consecutive births in Denmark between 1978 and 2016, a total of 1540 infants died of SIDS. A higher rate of SIDS was observed among siblings of children who died of SIDS compared with the general population. These findings suggest that any sibling of a child who died of SIDS should be investigated with great care to exclude genetic and environmental factors.

news Latest News and Publications
Adherence to NCCN Genetic Testing Guidelines in Pancreatic Cancer and Impact on Treatment. External Web Site Icon
Fionnuala Crowley et al. The oncologist 2023
How do members of the public expect to use variants of uncertain significance in their health care? A population-based survey. External Web Site Icon
Chloe Mighton et al. Genetics in medicine : official journal of the American College of Medical Genetics 2023 100819
Prophylactic salpingectomy with delayed oophorectomy as a two-staged alternative for primary prevention of ovarian cancer in BRCA1/2 mutation carriers: women's point of view. External Web Site Icon
Aya Mohr-Sasson et al. Menopause (New York, N.Y.) 2023
Rare Dysfunctional Complement Factor I Genetic Variants and Progression to Advanced Age-Related Macular Degeneration. External Web Site Icon
Johanna M Seddon et al. Ophthalmology science 2023 3(2) 100265
Are population level familial risks and germline genetics meeting each other? External Web Site Icon
Kari Hemminki et al. Hereditary cancer in clinical practice 2023 21(1) 3
Assessment of a Peer Physician Coaching Partnership Between a Designated Cancer Center Genetics Service and a Community Cancer Network Hospital. External Web Site Icon
Lauren G Santos et al. JAMA network open 2023 6(3) e231723
Association of Breast Cancer Family History With Breast Density Over Time in Korean Women. External Web Site Icon
Thi Xuan Mai Tran et al. JAMA network open 2023 6(3) e232420
BRCA1 and BRCA2 germline mutation analysis from a cohort of 1267 patients at high risk for breast cancer in Brazil. External Web Site Icon
Patricia Mazzonetto et al. Breast cancer research and treatment 2023
Characterization of Chronic Urticaria and Associated Conditions - A Web-Based Survey. External Web Site Icon
Weronika Zysk et al. Dermatology practical & conceptual 2023 13(1)
Rare germline variants in pancreatic cancer and multiple primary cancers: an autopsy study. External Web Site Icon
Hiroo Fujitani et al. European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP) 2023


Disclaimer: Articles listed in the Public Health Knowledge Base are selected by the CDC Office of Public Health Genomics to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.